BLOGS WEBSITE

TAG: CDK4/6

Research Impact – Bench to bedside – CDK4/6 inhibitor for prostate cancer in trial

Reported in the journal Oncogene in 2013, Professor Lisa Butler (pictured left) and collaborators, including the Centre’s Professor Wayne Tilley and senior author, Professor┬áKaren Knudsen from the Kimmel Cancer Center, Thomas Jefferson University in USA. inhibition of the cyclin/cyclin-dependent kinase/retinoblastoma (CDK4/6) pathway that is critical for cell replication may have a role in controlling some […]

Posted in News, Research | Tagged , , , |

Comments Off on Research Impact – Bench to bedside – CDK4/6 inhibitor for prostate cancer in trial